Asian Phytoceuticals PCL 2020 SR
The report highlights Asian Phytoceuticals Public Company Limited's (APCO) sustainability performance for the fiscal year 2020. Amidst the COVID-19 pandemic, the company expanded its business through joint ventures in China and digital channels while prioritizing employee health by providing immunization products. APCO continued its commitment to innovation with its 'Innovative Plant-Based HIV Immunotherapy' and maintained its 'white business' policy with zero corruption complaints. On the environmental front, the company reduced its water consumption to 4,245 cubic meters and managed waste systematically, while maintaining zero workplace injuries.
Company: Asian Phytoceuticals PCL
Sector: Manufacturing
Country: Thailand
Year: 2020
Type: SR
Pages: 49
Back to company
Asian Phytoceuticals PCL
Sustainability Report
The report highlights Asian Phytoceuticals Public Company Limited's (APCO) sustainability performance for the fiscal year 2020. Amidst the COVID-19 pandemic, the company expanded its business through joint ventures in China and digital channels while prioritizing employee health by providing immunization products. APCO continued its commitment to innovation with its 'Innovative Plant-Based HIV Immunotherapy' and maintained its 'white business' policy with zero corruption complaints. On the environmental front, the company reduced its water consumption to 4,245 cubic meters and managed waste systematically, while maintaining zero workplace injuries.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2020
Reporting Period
Jan 1, 2020 - Dec 31, 2020
Fiscal Year
2020
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Water Consumption
Women on Board
Workplace Fatalities
Employees